BlessUp · Peptide Library · Recovery & Repair
BPC-157, TB-500 and GHK-Cu, the three recovery peptides people reach for, and the honest picture of what they can and cannot do.
Three peptides, three different jobs, one repair job. Real mechanism, a thin human record, and a combination nobody has ever tested in people.
Per PubMed: Mateescu DM, et al. Pharmaceutics. 2026. doi:10.3390/pharmaceutics18050625. Peptide profiles from the BlessUp Peptide Library and the OnePin compound data.
If you have a nagging tendon, a fresh injury, a gut that will not settle, or you just want to heal faster, you have probably heard these three names thrown around like a magic recipe.
Here is the honest version. BPC-157, TB-500 and GHK-Cu are the recovery peptides most people meet first, and there is real, interesting biology behind each one. There is also a thin human record behind all of them, and a lot of confident internet claims that run way past the evidence. This guide gives you both sides: what each one actually does, how the famous stacks fit together, the one safety rule that trips people up, and where the honest limits are. You will leave knowing how to run this smart, or knowing it is not worth it for you yet. Either answer is a win.
Read this first
This is education, not medical advice, and it does not replace your own clinician or your own labs. These are research peptides, not FDA-approved medicines. Compounds and doses named here are examples for discussion, not a prescription. For research and educational purposes, adults 21 and over.
90-second self-check
Answer honestly. This is a reflection tool, not a diagnosis, and it does not replace a real conversation with a provider.
Answer the dropdown, then tap everything that is true for you.
How solid is your recovery foundation right now, protein, sleep, and managing the load on the injured tissue?
What are you mainly trying to heal?
Which of these describe your plan? (tap all that apply)
Any of these true? (tap all that apply)
This reflection is education only, not a diagnosis. What you actually heal is decided by the basics and by a real provider, not by a quiz.
The basics
Peptides are short chains of amino acids, the same building blocks your body already uses to signal repair. These three are signals, not steroids and not painkillers. They do not force growth or numb a problem. They nudge processes your body already runs: growing blood vessels, moving repair cells into damaged tissue, and building collagen. That is why they are called a recovery "stack", each one covers a different part of the same job.
BPC-157 is the local specialist. It drives new blood-vessel growth and cell repair right where you inject it, which is why it has a reputation for tendon, ligament and gut healing, the places blood supply is normally poor. TB-500 is the systemic counterpart. It regulates actin, the internal scaffolding that lets cells move, so repair cells migrate to wherever the damage is, body-wide, from a single weekly dose. GHK-Cu is the builder. It is a copper-carrying tripeptide that switches on collagen and elastin production and shifts your gene expression toward repair and away from inflammation. One builds the supply line, one moves the crew, one lays the scaffold.
The half-truth you will hear: "TB-500 is thymosin beta-4"
Not exactly, and it matters. Thymosin beta-4 is the natural 43-amino-acid protein. "TB-500" is a trade name for a shorter fragment built around its active motif. The catch: vendors are inconsistent, some vials are the full protein, some are the fragment, and the label rarely says which. Every human study in the evidence base used the full protein, not the fragment most people inject. This is exactly why a certificate of analysis matters more here than with a tightly-defined drug.
How strong is the evidence, really
The mechanisms below are genuinely well characterized, but almost entirely in animal and cell-culture work. Human data is early and small. According to PubMed, a 2026 review found BPC-157 has no approved formulation, no validated dose, and no completed Phase II trial, with total human experience of fewer than 30 people across three uncontrolled pilots. GHK-Cu has never been trialed as an injectable in humans at all, its human evidence is entirely topical. Read the mechanisms as promising, not proven.
Where each one actually stands on human evidence
A rough read of how far each has been tested in people, not a precision score.
Per PubMed: Mateescu DM 2026 (doi:10.3390/pharmaceutics18050625); Kleinman & Sosne 2016 (PMID 27450738); Pickart & Margolina 2018 (PMID 29986520). Bar lengths are an editorial summary of trial maturity.
Under the hood
Up-regulates VEGF and the nitric-oxide system to grow new blood vessels into injured tissue, delivering oxygen and nutrients where blood normally struggles to reach.
Binds actin and drives cell migration so repair cells travel to the damage from anywhere in the body, plus it limits scar tissue as things rebuild.
Delivers copper to the enzyme that cross-links collagen and elastin, and flips gene expression toward building structure and away from inflammation.
On paper it is a tidy division of labor, and that logic is exactly why the stacks became popular. The honest caveat: this complementary picture is a reasonable theory built from each peptide's separate animal data. No study has run the three together in people to confirm they add up the way the diagram suggests.
The question everyone actually wants answered
The core biology is real and repeatable. BPC-157 accelerates tendon, ligament and gut healing across many animal models, and its animal safety margin is remarkable, researchers could not establish a lethal dose. Thymosin beta-4 has decades of solid wound-healing and anti-inflammatory data, including early human trials for dermal wounds. GHK-Cu is a natural human molecule with genuine, published clinical results for skin when applied topically. None of this is snake oil.
Whether any of it reliably works in humans by injection, at what dose, for how long, and whether the famous stack is better than one peptide alone. The human record for BPC-157 is fewer than 30 people in uncontrolled pilots. The fragment sold as TB-500 has never been trialed as sold. Injectable GHK-Cu has no human trials whatsoever. And the combination has never been formally studied in a person. Anyone telling you the stack is "clinically proven" is selling, not citing.
Where caution is genuinely warranted
These peptides promote cell migration and new blood-vessel growth. That is the whole point for healing, but it is also a theoretical reason for real caution if you have an active or prior cancer concern, because those same processes can feed tumors. That is a provider conversation, not a community one. TB-500 is also banned in tested sport (WADA S2), and GHK-Cu should be avoided if you have Wilson's disease or another copper disorder.
The numbers to know
One of the most common mistakes is dosing all three the same way. They clear the blood in minutes to hours, but their repair signal lasts wildly different lengths of time, so their schedules are not interchangeable. Here is the cadence each one is actually run on.
How often each is typically dosed
Example reference schedules from community practice, not a prescription. Finalize any real protocol with a provider.
Peptide profiles from the BlessUp Peptide Library and OnePin compound data. TB-500's weekly cadence reflects a repair-signal that lasts 4 to 7 days despite a plasma half-life of hours.
Why the schedules differ
BPC-157 and GHK-Cu leave the blood fast and their effect fades within a day, so they are dosed daily to keep the signal present. TB-500's molecule also clears in hours, but the cell-migration process it kicks off runs for the better part of a week, so a single weekly pin does the job. Judge all three over weeks, not hours.
When it shows up, and when it settles
What people generally report over a cycle
Illustrative shape based on the literature and community reports, not a promise for any one person.
Composite of the BPC-157, TB-500 and GHK-Cu response timelines. Acute issues can move in days; chronic ones need the full block.
Days 1 to 7. Often quiet, though BPC-157 can take the edge off an acute injury within a couple of days. TB-500 and GHK-Cu work through slow processes, migration and gene expression, so week one rarely feels dramatic. Do not read the quiet as failure and pile on more.
Weeks 2 to 6. The window most people notice something: less day-to-day soreness, easier range of motion, chronic niggles starting to respond, and, for GHK-Cu, early skin texture change.
Weeks 6 to 12. The cumulative, structural stretch, collagen remodeling and scar softening consolidate. Plan to cycle off at 8 to 12 weeks rather than running open-ended.
Before you credit or blame the peptide
It is easy to give a peptide all the credit or all the blame, when the real driver was something more basic. Rule these in or out first, because the best stack in the world cannot outrun them.
The toolkit, with honest pros and cons
Here is every piece of the healing stack as its own card, with the real trade-offs, not just the upside. Tags show whether each is mainly for a short-term acute push, a longer-term rebuild, or both. Every dose is an example to finalize with a provider.
Drives blood-vessel growth and cell repair at the site. Example: 250 mcg once daily, up to 500 mcg for an acute injury, 12 weeks on then 4 off.
Monitor: the actual outcome, pain, range of motion, gut symptoms. Baseline bloodwork is sensible. Per PubMed, Seiwerth 2021 (PMID 34267654); Chang 2010 (PMID 21030672).
Actin-driven cell migration, body-wide, plus anti-scarring. Example: 2 mg once weekly, optional short loading if recovery lags, 8 to 12 weeks on then 4 off.
Monitor: recovery between sessions and range of motion; insist on a certificate of analysis. Per PubMed, Goldstein 2005 (PMID 16099219); Kleinman & Sosne 2016 (PMID 27450738).
Copper delivery for collagen cross-linking plus a repair gene-expression switch. Example: topical 1 to 2 percent for skin; if injecting, 1 mg daily, 4 to 8 weeks on then 4 off.
Monitor: skin, wound and scar change; copper and ceruloplasmin if dosing high long-term. Per PubMed, Pickart & Margolina 2018 (PMID 29986520); Pickart 2015 (PMID 26236730).
The core pairing: local repair from BPC-157, whole-body repair from TB-500. Run as two separate pins on their own schedules.
Monitor: keep them as separate pins (BPC daily, TB weekly); track one clear outcome so you can judge if the second peptide earned its place.
GLOW adds GHK-Cu's scaffold-building to the repair crew; KLOW adds the anti-inflammatory peptide KPV on top. Overlapping repair and anti-inflammatory coverage.
Monitor: respect the copper rule (next). Never mix GHK-Cu with full-length TB-500 in one syringe.
The one safety rule people get wrong: the copper rule
GHK-Cu carries copper, and copper degrades certain other peptides on contact. So in any multi-peptide draw, draw GHK-Cu last, and never mix it in the same syringe with full-length TB-500, with VIP, or with CJC-1295 that contains DAC, the copper destroys them. GHK-Cu can safely share a syringe with BPC-157 and KPV. When in doubt, use separate pins. This is a handling rule, not a suggestion.
Put it together
Fresh injury, right now
So the tissue stays resilient
The one rule, if you take nothing else
The peptide is the signal. Protein, sleep, load management and rehab are what actually rebuild the tissue. Get those right first, and the stack has something to amplify. Skip them, and no peptide will save the outcome.
The foundation under everything
Adequate daily protein is non-negotiable, it is the raw material every one of these peptides is signaling for. Pair it with vitamin C (a required cofactor for building collagen) and enough overall calories, because the body does not do major repair in a deep deficit.
This is where recovery physically happens. Growth hormone pulses and tissue repair are concentrated in deep sleep. Protect 7 to 9 hours the way you would protect a training session, it is that load-bearing.
Healing tissue needs a reason to rebuild stronger, which means progressive, controlled loading and proper rehab, not just rest and not just a needle. The peptide supports the work; it does not replace it.
Nicotine and heavy alcohol work directly against every goal here, one starves tissue of blood flow, the other sabotages collagen and sleep. Cutting them is one of the highest-leverage moves you can make.
Cutting through the noise
Well-established roles in tissue repair and collagen biology. Correcting a real deficiency here reliably improves the terrain the peptides are working in.
Sensible support with modest direct evidence. Creatine helps the strength work that turns healed tissue into resilient tissue; magnesium supports sleep.
The stack is a reasonable theory and a popular convention. It has never been tested as a combination in humans. Treat synergy claims as plausible, not established.
Concentrated anti-angiogenic extracts can oppose the very blood-vessel growth BPC-157 depends on (culinary amounts in food are fine). Chronic anti-inflammatories can blunt tendon healing. Never stop a prescribed medication for this, raise timing with your provider.
The honest bottom line on the stack
Used well, the healing stack is a support signal layered on top of a solid recovery foundation, for someone who has ruled out a problem that needs a surgeon, respects the copper rule, sources carefully, and gives it a real multi-week runway. Used badly, it is an expensive way to inject research chemicals of uncertain quality while ignoring the sleep and protein that would have done more. The biology is genuinely interesting. The human proof is genuinely thin. Both things are true, and a steward holds both.
Running any of these? OnePin stores the verified compound profiles, does your reconstitution math to the exact unit, schedules the daily or weekly reminders, flags the copper draw-last rule, and logs each cycle so you can actually tell what worked.
Turn this into action
Are my protein, sleep and load management actually dialed in, or am I hoping a peptide covers for them?
Has this injury been properly assessed, or could it be something that needs imaging and a provider?
Do I have a certificate of analysis for anything I am putting in my body?
Do I understand the copper rule before I stack GHK-Cu with anything?
Am I giving this a real cycle with an end date, or drifting into open-ended use?
Bring these to your visit
Given my history, is a pro-migration, pro-angiogenic signal safe for me, especially any cancer history?
Does this injury actually need imaging or a specialist before I try to heal it at home?
Do any of my medications interact with what I am considering, and how should I time them?
These are not routine "push through it" situations, they are reasons to pause and get real input.
And the quiet one that matters most: no certificate of analysis and no idea what is really in the vial. Source quality is the biggest safety lever you control.
The BlessUp take
The healing stack is a real signal with real biology and a genuinely thin human record. Promising, not proven, and the combination has never been trialed in a single person. So run it like a steward, not a gambler: minimum effective dose, respect the copper rule, source with a certificate of analysis, give it the full runway, and cycle off. Above all, remember the order of operations. The peptide is the spark. Protein, sleep, load and rehab are the fire. Build the foundation, then decide if the signal is worth adding on top. Your body does the healing. Everything here just tries to help it along.
The evidence
Per PubMed. Mechanism and human-evidence claims trace to the peer-reviewed literature below; dosing and handling reflect community and OnePin compound data and are examples to finalize with a provider, not trial-validated regimens.